<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04706338</url>
  </required_header>
  <id_info>
    <org_study_id>KY-2020-128-01</org_study_id>
    <nct_id>NCT04706338</nct_id>
  </id_info>
  <brief_title>Transcranial Magnetic Stimulation in the Rehabilitation of Postoperative Motor Dysfunction.</brief_title>
  <acronym>ATM</acronym>
  <official_title>A Study of Transcranial Magnetic Stimulation in the Rehabilitation of Glioma Patients With Postoperative Motor Dysfunction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Neurosurgical Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Neurosurgical Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study focused on glioma patients with postoperative motor deficits, especially for&#xD;
      patients with supplementary motor area syndrome. The investigators want to investigate&#xD;
      whether the recovery of motor function will be accelerated by using transcranial magnetic&#xD;
      stimulation to stimulate primary motor area and supplementary motor area on the lesional&#xD;
      hemisphere.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>patients with postoperative motor deficits, especially for patients with SMA syndrome.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accelerate motor functional recovery</measure>
    <time_frame>From the day of tumor resection to 3 months after tumor resection.</time_frame>
    <description>The ratio of motor functional recovery in patients with TMS treatment is higher than those do not receive TMS treatment and the time of motor funcitonal recovery is shorter than those do not receive.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Glioma</condition>
  <condition>Postoperative Motor Deficit</condition>
  <arm_group>
    <arm_group_label>TMS treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with TMS treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TMS treatment</intervention_name>
    <description>Using TMS to stimulate (5 Hz, 90%~110% resting motor threshold) patients' primary motor area and SMA.</description>
    <arm_group_label>TMS treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. patient underwent awake craniotomy and motor functional identification during tumor&#xD;
             resection;&#xD;
&#xD;
          2. patients with postoperative motor deficit (muscle strength of limbs is weaker than&#xD;
             preoperative status)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. patients with contraindication of transcranial magnetic stimulation;&#xD;
&#xD;
          2. patients without data of the pre- and postoperative resting state MRI and diffusion&#xD;
             tensor image.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jiang Tao</last_name>
    <role>Study Chair</role>
    <affiliation>Beijing Neurosurgical Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shengyu Fang, MD</last_name>
    <phone>+8613466331405</phone>
    <email>fangtuo1@aliyun.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yinyan Wang, MD</last_name>
    <phone>+8613581688953</phone>
    <email>tiantanyinyan@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Neurosurgical Institute and Beijing Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100005</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Jiang, MD and PhD</last_name>
      <phone>+86-010-67021832</phone>
      <email>taojiang1964@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Dionísio A, Duarte IC, Patrício M, Castelo-Branco M. The Use of Repetitive Transcranial Magnetic Stimulation for Stroke Rehabilitation: A Systematic Review. J Stroke Cerebrovasc Dis. 2018 Jan;27(1):1-31. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.008. Epub 2017 Oct 27. Review.</citation>
    <PMID>29111342</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, Filipović SR, Grefkes C, Hasan A, Hummel FC, Jääskeläinen SK, Langguth B, Leocani L, Londero A, Nardone R, Nguyen JP, Nyffeler T, Oliveira-Maia AJ, Oliviero A, Padberg F, Palm U, Paulus W, Poulet E, Quartarone A, Rachid F, Rektorová I, Rossi S, Sahlsten H, Schecklmann M, Szekely D, Ziemann U. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clin Neurophysiol. 2020 Feb;131(2):474-528. doi: 10.1016/j.clinph.2019.11.002. Epub 2020 Jan 1. Review. Erratum in: Clin Neurophysiol. 2020 May;131(5):1168-1169.</citation>
    <PMID>31901449</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 10, 2021</study_first_submitted>
  <study_first_submitted_qc>January 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2021</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The treatment protocal of TMS for glioma patients with postoperative motor dysfunction</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

